Skip to main content
Malin Corporation Plc logo

Malin Corporation Plc — Investor Relations & Filings

Ticker · MLC ISIN · IE00BVGC3741 LEI · 635400JG4YSDU5U1YU17 IR Financial and insurance activities
Open in API
Filings indexed 179 across all filing types
Latest filing 2025-03-21 Transaction in Own Shar…
Country IE Ireland
Listing IR MLC

About Malin Corporation Plc

http://malinplc.com/

Malin Corporation Plc is an investment company that provides long-term capital and operational expertise to highly innovative life sciences companies. The company focuses on private businesses operating in the therapeutics, medical devices, and diagnostics sectors. Its investment strategy is concentrated on specific therapeutic areas, primarily oncology, immunology, and genetic diseases. Malin supports its portfolio companies across various stages of development, from initial science and discovery through to clinical and commercial phases, with the objective of fostering the development of transformative technologies and outcomes for patients.

Recent filings

Filing Released Lang Actions
Acquisition of Tender Offer Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from Malin Corporation plc regarding the acquisition and subsequent cancellation of its own shares following a tender offer. This falls under the category of a company buying back its own shares, which is classified as 'Transaction in Own Shares' (POS).
2025-03-21 English
Results of Tender Offer
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Malin Corporation PLC regarding the results of a 'Tender Offer'. It details the oversubscription of the offer, the number of shares acquired, the scale-back mechanism, and the timeline for payment to shareholders. Since this document reports on the company buying back its own shares through a tender offer, it falls under the category of 'Transaction in Own Shares'.
2025-03-21 English
Result of AGM & EGM
AGM Information Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 6001A' and the footer mentioning RNS/LSE) reporting the 'Results of Annual General Meeting ("AGM") and Results of Extraordinary General Meeting ("EGM")'. It explicitly states that resolutions proposed to shareholders were passed by poll vote at both meetings. This content directly relates to the outcomes of shareholder meetings. The most specific category for official results from shareholder votes is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). While it mentions the AGM, the core content is the result announcement, not the AGM presentation materials (AGM-R) or the proxy solicitation materials (PSI).
2025-03-13 English
2024 Full Year Results & Notice of AGM
Regulatory Filings Classification · 98% confidence The document explicitly states it 'today publishes its full year results and annual report for the year ended 31 December 2024.' It also mentions the '2024 Full Year Results and Notice of 2025 AGM' and provides key financial highlights typical of an annual results announcement. Although it mentions the AGM documents being issued, the primary content is the comprehensive summary of the full year financial performance and investment updates, which aligns best with the Annual Report (10-K) definition, even if it's a non-US filing format that includes the results summary. The length (11,959 chars) suggests it is more than just a brief announcement (RPA/RNS). Since the text contains the full year results and annual report information, 10-K is the most appropriate classification for comprehensive annual reporting.
2025-02-19 English
Proposed Tender Offer
AGM Information Classification · 99% confidence The document is an RNS announcement from Malin Corporation PLC detailing a 'Proposed Return of Capital of up to €150 million by way of Tender Offer' and includes a 'Notice of Extraordinary General Meeting' (EGM) required to approve the offer. A tender offer is a mechanism for a company to buy back its own shares from shareholders, which directly corresponds to the definition of 'Transaction in Own Shares' (POS). While it involves capital structure changes (CAP) and shareholder voting (DVA), the core action being announced and detailed is the share repurchase via a tender offer. The document is a formal announcement (RNS Number: 5930X) detailing the terms, timeline, and required shareholder vote for this capital return/share repurchase program. Therefore, POS is the most specific classification, although RPA or DVA are secondary possibilities due to the EGM notice and the announcement format. Given the focus on the tender offer mechanism for buying back shares, POS is selected.
2025-02-19 English
Update on Return of Capital to Shareholders
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 9228V' and the footer referencing RNS/LSE) dated February 5, 2025. The primary subject is an 'Update on Return of Capital to Shareholders' via a tender offer. While it mentions the upcoming release of the 'annual report for the year ending 31 December 2024' on February 19, 2025, the current document itself is an announcement regarding a capital structure event (tender offer/return of capital). This type of announcement, which details a specific corporate action like a tender offer or capital return, fits best under 'Capital/Financing Update' (CAP). It is not the full 10-K, nor is it just a notice about the publication of a report (RPA), as it contains substantive details about the tender offer terms (€150 million, €10.30 per share).
2025-02-05 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.